Abeona Therapeutics, Inc. - Multiplikator EV/Sales ABEO

Logo perusahaan publik Abeona Therapeutics, Inc. (ABEO)

Abeona Therapeutics (ABEO) demonstrates high resilience to macroeconomic shocks, as demand for orphan drugs remains independent of market cycles. The price-to-sales multiple visualizes the current market valuation, with the 556.27 value indicating the asset's status. However, geopolitical tensions complicate the transportation of biomaterials, although the modernization of sterile facilities ensures the stable production of cell products.

Abeona Therapeutics Inc. - Rasio nilai perusahaan marang pendapatan ABEO (periode 23.11.2025 - 20.11.2026)

Abeona Therapeutics - rincian analitis lan metrik utama (ABEO)

- informasi babagan dhuwit lan arus kas:
Pambiji fundamental perusahaan:Abeona Therapeutics, Inc. - ABEO
Produk seri Abeona

This ratio determines the market value of the business, accounting for net debt relative to generated revenue. By analyzing the enterprise value-to-revenue chart, an investor identifies actual capital accumulation phases while filtering out speculative noise. The metric compares the total cost of acquiring the asset with its operational efficiency. This is critical for Abeona Therapeutics (ABEO), as the high scalability of gene therapy promises colossal margins. The indicator's dynamics here reflect market expectations for the future commercialization of unique drugs.